Dapa Met 5/850 Mg Tablets 28s – Optimized Combo for Type 2 Diabetes Control
Dapa Met 5/850 Mg Tablets 28s – Optimized Combo for Type 2 Diabetes Control
Dapa Met 5/850 Mg Tablets 28s – Optimized Combo for Type 2 Diabetes Control
Description
Dapa Met 5/850 Mg Tablets – Synergistic SGLT2 and Biguanide for Glycemic Balance
Dapa Met 5/850 Mg Tablets blend dapagliflozin 5mg, an SGLT2 inhibitor, with metformin 850mg, a biguanide, to provide robust management of type 2 diabetes in adults through complementary actions: dapagliflozin facilitates glucose removal via urine, and metformin curbs liver glucose output while boosting insulin sensitivity. This formulation helps achieve better blood sugar stability, potentially lowering the risk of cardiovascular events and supporting kidney health, ideal for patients transitioning from monotherapy or needing adjusted dosing. Packaged in 28 tablets for a month's supply, it encourages adherence with once-daily intake alongside healthy habits, always under healthcare provider direction.
